GFP tagging of Brucella melitensis Rev1 allows the identification of vaccinated sheep.


Journal

Transboundary and emerging diseases
ISSN: 1865-1682
Titre abrégé: Transbound Emerg Dis
Pays: Germany
ID NLM: 101319538

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 02 07 2018
revised: 17 10 2018
accepted: 22 10 2018
pubmed: 31 10 2018
medline: 5 3 2019
entrez: 31 10 2018
Statut: ppublish

Résumé

Brucellosis is a worldwide zoonosis causing important economic loss and a public health problem. Small ruminants are the preferred hosts of Brucella melitensis and thus the main source of human infections. Effective control of sheep and goat brucellosis has been achieved in several countries through vaccination with the live-attenuated B. melitensis Rev1 vaccine. However, Rev1 induces a long-lasting serological response that hinders the differentiation between infected and vaccinated animals. A Rev1::gfp strain expressing constitutively the Green Fluorescent Protein (GFP) was built by stable insertion of a mini-Tn7-gfp in the glmS-recG non-codifying chromosomal region. An associated indirect ELISA-GFP was developed to identify anti-GFP antibodies in vaccinated animals. The resulting Rev1::gfp kept the biological properties of the Rev1 reference strain, including residual virulence and efficacy in mice, and was readily distinguished from Rev1 and other Brucella field strains by direct visualization under ultraviolet illumination, fluorescence microscopy and a multiplex PCR-GFP. The Rev1::gfp strain did not elicit anti-GFP antibodies itself in lambs but when applied in combination with recombinant GFP induced an intense and long-lasting (>9 months) anti-GFP serological response readily detectable by the ELISA-GFP. Overall, our results confirm that Rev1 GFP-tagging can be a suitable alternative for identifying vaccinated sheep in infected contexts.

Identifiants

pubmed: 30375177
doi: 10.1111/tbed.13053
pmc: PMC7379934
doi:

Substances chimiques

Brucella Vaccine 0
Immunoglobulin G 0
Luminescent Agents 0
Vaccines, Attenuated 0
Green Fluorescent Proteins 147336-22-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

505-516

Subventions

Organisme : Secretaría de Estado de Investigación, Desarrollo e Innovación
ID : AGL2011-30453-C04-01
Organisme : Secretaría de Estado de Investigación, Desarrollo e Innovación
ID : AGL2014-58795-C04
Organisme : Secretaría de Estado de Investigación, Desarrollo e Innovación
ID : RTC-2015-3618-1
Organisme : CSIC-CRUSA Foundation bilateral project
ID : 2010CR0005

Informations de copyright

© 2018 Blackwell Verlag GmbH.

Références

Vaccine. 2007 Jan 15;25(5):794-805
pubmed: 17070627
Microb Biotechnol. 2015 Jan;8(1):177-87
pubmed: 25488129
Res Microbiol. 2000 Oct;151(8):655-68
pubmed: 11081580
Antimicrob Agents Chemother. 2009 Jan;53(1):298-302
pubmed: 19015361
Transbound Emerg Dis. 2019 Jan;66(1):505-516
pubmed: 30375177
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Vaccine. 2009 Jan 7;27(2):187-91
pubmed: 19007836
Infect Immun. 2004 Oct;72(10):5535-47
pubmed: 15385450
J Microbiol Biotechnol. 2009 Mar;19(3):217-28
pubmed: 19349746
Infect Immun. 1998 Aug;66(8):3862-6
pubmed: 9673273
Vet Immunol Immunopathol. 2016 Mar;171:81-102
pubmed: 26964721
PLoS Negl Trop Dis. 2012;6(10):e1865
pubmed: 23145195
Biologicals. 2000 Jun;28(2):119-27
pubmed: 10885618
PLoS One. 2008 Jul 23;3(7):e2760
pubmed: 18648644
Vet Res. 2004 Jan-Feb;35(1):1-38
pubmed: 15099501
Vaccine. 2009 Mar 10;27(11):1741-9
pubmed: 19186196
Lab Anim. 2000 Oct;34(4):329-50
pubmed: 11072854
Vaccine. 1990 Oct;8(5):462-8
pubmed: 2123586
J Inorg Biochem. 2013 Nov;128:237-44
pubmed: 23932735
Front Microbiol. 2014 May 13;5:213
pubmed: 24860561
J Antimicrob Chemother. 2006 Sep;58(3):622-6
pubmed: 16849379
Vaccine. 2006 Apr 24;24(17):3461-8
pubmed: 16519974
Ann Rech Vet. 1982;13(4):295-301
pubmed: 7185320
Ann Rech Vet. 1985;16(4):351-6
pubmed: 4091489
Nat Methods. 2005 Jun;2(6):443-8
pubmed: 15908923
Vaccine. 2004 Jul 29;22(21-22):2827-35
pubmed: 15246618
Nat Protoc. 2006;1(1):153-61
pubmed: 17406227
Appl Environ Microbiol. 2006 Jan;72(1):753-9
pubmed: 16391115
Prev Vet Med. 1997 Aug;31(3-4):275-83
pubmed: 9234451
Mol Biochem Parasitol. 1991 Aug;47(2):247-50
pubmed: 1840626
Front Biol (Beijing). 2013 Feb 1;8(1):60-77
pubmed: 23730309
Vet Res. 2012 Apr 13;43:29
pubmed: 22500859
Vet Clin North Am Food Anim Pract. 2011 Mar;27(1):95-104
pubmed: 21215893
Vaccine. 2008 Jun 19;26(26):3242-51
pubmed: 18468739
Vaccine. 2011 Jan 10;29(3):577-82
pubmed: 21056079

Auteurs

Ana Zabalza-Baranguá (A)

Instituto de Agrobiotecnología (IdAB, CSIC-Gobierno de Navarra), Mutilva, Navarra, Spain.

Beatriz San-Román (B)

Instituto de Agrobiotecnología (IdAB, CSIC-Gobierno de Navarra), Mutilva, Navarra, Spain.

Carlos Chacón-Díaz (C)

Centro de Investigación en Enfermedades Tropicales, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.

María-Jesús de Miguel (MJ)

Centro de Investigación y Tecnología Agroalimentaria (CITA), Instituto Agroalimentario de Aragón (IA2), Gobierno de Aragón, Zaragoza, Spain.

Pilar-María Muñoz (PM)

Centro de Investigación y Tecnología Agroalimentaria (CITA), Instituto Agroalimentario de Aragón (IA2), Gobierno de Aragón, Zaragoza, Spain.

Maite Iriarte (M)

Instituto de Salud Tropical - Dpto. de Microbiología y Parasitología, Universidad de Navarra, Pamplona, Spain.

José-María Blasco (JM)

Centro de Investigación y Tecnología Agroalimentaria (CITA), Instituto Agroalimentario de Aragón (IA2), Gobierno de Aragón, Zaragoza, Spain.

María-Jesús Grilló (MJ)

Instituto de Agrobiotecnología (IdAB, CSIC-Gobierno de Navarra), Mutilva, Navarra, Spain.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH